The development of RP-ILD in patients with IIM has been associated with various factors, including advanced age, elevated serum ferritin levels, and anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibodies. This evidence concerns the gene IFIH1 and retinitis pigmentosa 1.